Tango Therapeutics, Inc. (TNGX) Operating cash flow 2020–2025
Tango Therapeutics, Inc. (TNGX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$138.9MFY2025 · since FY2020: $70.1M → -$138.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$138.9M | -5.6% |
| FY2024 | -$131.5M | -11.5% |
| FY2023 | -$118.0M | -8.2% |
| FY2022 | -$109.1M | -83.2% |
| FY2021 | -$59.5M | -184.9% |
| FY2020 | $70.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice